FDA Approved: DUPIXENT — Original Application (sanofi-aventis U.S. LLC)

View source ↗

Summary

The FDA approved the original application for Dupixent (dupilumab) from Sanofi-U.S. LLC, marking the first approval of the medicine for atopic dermatitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• DUPIXENT (DUPILUMAB)

Snippet

ORIG AP for DUPIXENT (DUPILUMAB)